Kingswood Wealth Advisors LLC Has $980,000 Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Kingswood Wealth Advisors LLC lowered its holdings in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 33.0% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 3,265 shares of the company's stock after selling 1,606 shares during the quarter. Kingswood Wealth Advisors LLC's holdings in HCA Healthcare were worth $980,000 at the end of the most recent quarter.

Other institutional investors also recently modified their holdings of the company. Vista Investment Partners LLC grew its stake in shares of HCA Healthcare by 2.8% during the fourth quarter. Vista Investment Partners LLC now owns 8,463 shares of the company's stock worth $2,540,000 after purchasing an additional 230 shares during the period. Geneos Wealth Management Inc. grew its position in HCA Healthcare by 2.3% in the fourth quarter. Geneos Wealth Management Inc. now owns 3,309 shares of the company's stock valued at $993,000 after purchasing an additional 73 shares in the last quarter. Fifth Third Bancorp increased its holdings in shares of HCA Healthcare by 1.1% during the 4th quarter. Fifth Third Bancorp now owns 9,225 shares of the company's stock worth $2,769,000 after acquiring an additional 98 shares during the last quarter. Harel Insurance Investments & Financial Services Ltd. acquired a new position in HCA Healthcare in the 4th quarter valued at $115,000. Finally, Exchange Traded Concepts LLC lifted its position in shares of HCA Healthcare by 57.2% during the 4th quarter. Exchange Traded Concepts LLC now owns 1,608 shares of the company's stock valued at $483,000 after acquiring an additional 585 shares during the period. Institutional investors and hedge funds own 62.73% of the company's stock.

HCA Healthcare Trading Down 0.2 %

Shares of NYSE HCA traded down $0.69 during mid-day trading on Wednesday, reaching $328.01. 652,252 shares of the company's stock were exchanged, compared to its average volume of 1,754,151. The company's 50-day moving average is $313.28 and its 200-day moving average is $353.27. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $417.14. The firm has a market capitalization of $83.09 billion, a price-to-earnings ratio of 14.69, a PEG ratio of 1.09 and a beta of 1.64. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, beating analysts' consensus estimates of $6.03 by $0.19. HCA Healthcare had a return on equity of 520.98% and a net margin of 8.52%. During the same quarter in the previous year, the business posted $5.90 earnings per share. Analysts expect that HCA Healthcare, Inc. will post 21.75 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 17th will be paid a $0.72 dividend. This is a boost from HCA Healthcare's previous quarterly dividend of $0.66. This represents a $2.88 annualized dividend and a yield of 0.88%. The ex-dividend date of this dividend is Monday, March 17th. HCA Healthcare's payout ratio is currently 11.85%.

Wall Street Analysts Forecast Growth

HCA has been the topic of a number of research reports. Oppenheimer boosted their target price on shares of HCA Healthcare from $390.00 to $400.00 and gave the stock an "outperform" rating in a research note on Monday, October 28th. Wells Fargo & Company lowered shares of HCA Healthcare from an "equal weight" rating to an "underweight" rating and dropped their price objective for the company from $400.00 to $320.00 in a report on Monday, November 25th. Morgan Stanley reduced their price objective on shares of HCA Healthcare from $406.00 to $355.00 and set an "equal weight" rating for the company in a research report on Tuesday, December 17th. StockNews.com downgraded shares of HCA Healthcare from a "strong-buy" rating to a "buy" rating in a research report on Monday, November 4th. Finally, Royal Bank of Canada cut their price target on shares of HCA Healthcare from $405.00 to $384.00 and set an "outperform" rating for the company in a report on Monday. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $382.19.

Insider Transactions at HCA Healthcare

In related news, insider Erol R. Akdamar sold 2,900 shares of the stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total value of $1,023,700.00. Following the completion of the sale, the insider now directly owns 6,843 shares in the company, valued at approximately $2,415,579. This represents a 29.76 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Phillip G. Billington sold 3,897 shares of the firm's stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $350.00, for a total value of $1,363,950.00. Following the sale, the senior vice president now owns 52,702 shares of the company's stock, valued at $18,445,700. This represents a 6.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.60% of the company's stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.